We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Medical Students Trained in Genomics and Personalized Medicine

By LabMedica International staff writers
Posted on 14 Jul 2010
Doctors have recommended that genomics and personalized medicine become a core competency for all pathology trainees by 2012.

As a first step in leading this program, the department of pathology at Beth Israel Deaconess Medical Center (BIDMC; Boston, MA; USA) in collaboration with BIDMC's genetic counseling service, last year launched the Genomic Medicine Initiative, a compulsory program to prepare doctors-in-training to apply genomics and personalized medicine in their day-to-day practices.

Jeffrey Saffitz, M.D., Ph.D., and colleagues wrote in a special article in the June, 2010 edition of the American Journal Of Clinical Pathology (AJCP), "Genomics and 'medical sequencing' will revolutionize clinical laboratory diagnostics as the foundation for the new era of personalized medicine.....Pathologists must take the lead in the application of genomics technologies, including whole genome sequencing, laboratory technologies, and personalized medicine."

The new BIDMC pathology curriculum addresses these issues, with the new medical specialty built on three pillars: laboratory medicine, genetic counseling, and health information technology. More...
Richard Schwartzstein, M.D., vice president for education at BIDMC and a faculty dean for medical education at Harvard Medical School (Boston, MA, USA), explained, "The integration of genetic information will be the core of 'patient-centered' care."

Related Links:

Beth Israel Deaconess Medical Center
Harvard Medical School



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
Spinal Fluid Cell Count Control
Spinalscopics
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.